IDEAS home Printed from https://ideas.repec.org/a/ebl/ecbull/eb-19-00461.html
   My bibliography  Save this article

Off-label use of recreational cannabis: Acid reflux in Colorado

Author

Listed:
  • Jacqueline M. Doremus

    (California Polytechnic State University, San Luis Obispo)

  • Sarah S. Stith

    (University of New Mexico)

  • Jacob M. Vigil

    (University of New Mexico)

Abstract

Medical cannabis access has been shown to affect clinical health outcomes and health care spending. Unlike medical access, which requires a doctor's recommendation for treatment and only applies to the limited conditions approved under the state's medical cannabis program, recreational access makes cannabis available over-the-counter (OTC). This may create additional benefits through off-label cannabis use to treat unlisted conditions, such as acid reflux, which affects two out of three Americans. Using the roll out of recreational dispensaries in Colorado in 2014, we estimate the change in retailers' market share of antacid medications using a difference-in-differences design. Antacid market share decreases after a dispensary enters a county by 0.85 percentage points. Decreases come from histamine receptor antagonists and proton pump inhibitors. Decreased antacid use may occur through direct substitution for OTC antacids, through changes in dietary behaviors that reduce antacid use, or both. More work is needed to disentangle these two effects.

Suggested Citation

  • Jacqueline M. Doremus & Sarah S. Stith & Jacob M. Vigil, 2020. "Off-label use of recreational cannabis: Acid reflux in Colorado," Economics Bulletin, AccessEcon, vol. 40(1), pages 338-348.
    • Handle: RePEc:ebl:ecbull:eb-19-00461
    as

    Download full text from publisher

    File URL: http://www.accessecon.com/Pubs/EB/2020/Volume40/EB-20-V40-I1-P30.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Gary Solon & Steven J. Haider & Jeffrey M. Wooldridge, 2015. "What Are We Weighting For?," Journal of Human Resources, University of Wisconsin Press, vol. 50(2), pages 301-316.
    2. D. Mark Anderson & Daniel I. Rees, 2014. "The Legalization of Recreational Marijuana: How Likely Is the Worst‐Case Scenario?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 33(1), pages 221-232, January.
    3. Sonal S. Pandya & Rajkumar Venkatesan, 2016. "French Roast: Consumer Response to International Con flict--Evidence from Supermarket Scanner Data," The Review of Economics and Statistics, MIT Press, vol. 98(1), pages 42-56, March.
    4. D. Mark Anderson & Benjamin Hansen & Daniel I. Rees, 2013. "Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption," Journal of Law and Economics, University of Chicago Press, vol. 56(2), pages 333-369.
    5. Joseph J. Sabia & Jeffrey Swigert & Timothy Young, 2017. "The Effect of Medical Marijuana Laws on Body Weight," Health Economics, John Wiley & Sons, Ltd., vol. 26(1), pages 6-34, January.
    6. Ashley C. Bradford & W. David Bradford, 2018. "The Impact of Medical Cannabis Legalization on Prescription Medication Use and Costs under Medicare Part D," Journal of Law and Economics, University of Chicago Press, vol. 61(3), pages 461-487.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Smart, Rosanna & Doremus, Jacqueline, 2023. "The kids aren’t alright: The effects of medical marijuana market size on adolescents," Journal of Health Economics, Elsevier, vol. 87(C).
    2. Ziemowit Bednarek & Jacqueline Doremus & Sarah Stith, 2021. "U.S. Cannabis Laws Projected to Cost Generic and Brand Pharmaceutical Firms Billions," Working Papers 2102, California Polytechnic State University, Department of Economics.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alex Hollingsworth & Coady Wing & Ashley C. Bradford, 2022. "Comparative Effects of Recreational and Medical Marijuana Laws on Drug Use among Adults and Adolescents," Journal of Law and Economics, University of Chicago Press, vol. 65(3), pages 515-554.
    2. Sabia, Joseph J. & Dave, Dhaval & Alotaibi, Fawaz & Rees, Daniel I., 2024. "The effects of recreational marijuana laws on drug use and crime," Journal of Public Economics, Elsevier, vol. 234(C).
    3. Chu, Yu-Wei Luke & Townsend, Wilbur, 2019. "Joint culpability: The effects of medical marijuana laws on crime," Journal of Economic Behavior & Organization, Elsevier, vol. 159(C), pages 502-525.
    4. Carrieri, Vincenzo & Madio, Leonardo & Principe, Francesco, 2020. "Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs," Journal of Health Economics, Elsevier, vol. 74(C).
    5. Junxing Chay & Seonghoon Kim, 2022. "Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 269-283, February.
    6. Angela K. Dills & Sietse Goffard & Jeffrey Miron, 2017. "The Effects of Marijuana Liberalizations: Evidence from Monitoring the Future," NBER Working Papers 23779, National Bureau of Economic Research, Inc.
    7. Cameron M. Ellis & Martin F. Grace & Rhet A. Smith & Juan Zhang, 2022. "Medical cannabis and automobile accidents: Evidence from auto insurance," Health Economics, John Wiley & Sons, Ltd., vol. 31(9), pages 1878-1897, September.
    8. Michele Baggio & Alberto Chong & David Simon, 2018. "Sex, Drugs, and Baby Booms: Can Behavior Overcome Biology?," NBER Working Papers 25208, National Bureau of Economic Research, Inc.
    9. Mir M. Ali & Chandler McClellan & Ryan Mutter & Daniel I. Rees, 2023. "Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata," Health Economics, John Wiley & Sons, Ltd., vol. 32(2), pages 277-301, February.
    10. Keshar M. Ghimire & Johanna Catherine Maclean, 2020. "Medical marijuana and workers' compensation claiming," Health Economics, John Wiley & Sons, Ltd., vol. 29(4), pages 419-434, April.
    11. Raymond J. March & Veeshan Rayamajhee & Glenn L. Furton, 2022. "Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity," Health Economics, John Wiley & Sons, Ltd., vol. 31(12), pages 2609-2629, December.
    12. Baggio, Michele & Chong, Alberto & Simon, David, 2020. "Sex, marijuana and baby booms," Journal of Health Economics, Elsevier, vol. 70(C).
    13. Carrieri, Vincenzo & Madio, Leonardo & Principe, Francesco, 2019. "Light cannabis and organized crime: Evidence from (unintended) liberalization in Italy," European Economic Review, Elsevier, vol. 113(C), pages 63-76.
    14. Borbely, Daniel & Lenhart, Otto & Norris, Jonathan & Romiti, Agnese, 2022. "Marijuana Legalization and Mental Health," IZA Discussion Papers 15729, Institute of Labor Economics (IZA).
    15. Hansen, Benjamin & Miller, Keaton & Weber, Caroline, 2020. "Federalism, partial prohibition, and cross-border sales: Evidence from recreational marijuana," Journal of Public Economics, Elsevier, vol. 187(C).
    16. Dave, Dhaval & Liang, Yang & Pesko, Michael F. & Phillips, Serena & Sabia, Joseph J., 2023. "Have recreational marijuana laws undermined public health progress on adult tobacco use?," Journal of Health Economics, Elsevier, vol. 90(C).
    17. Chakraborty Avinandan & Doremus Jacqueline & Stith Sarah, 2021. "The effects of recreational cannabis access on labor markets: evidence from Colorado," IZA Journal of Labor Economics, Sciendo & Forschungsinstitut zur Zukunft der Arbeit GmbH (IZA), vol. 10(1), pages 1-86, January.
    18. Chu, Yu-Wei Luke & Gershenson, Seth, 2018. "High times: The effect of medical marijuana laws on student time use," Economics of Education Review, Elsevier, vol. 66(C), pages 142-153.
    19. Baggio, Michele & Chong, Alberto, 2020. "Recreational marijuana laws and junk food consumption," Economics & Human Biology, Elsevier, vol. 39(C).
    20. Armstrong, Michael J., 2023. "Relationships between sales of legal medical cannabis and alcohol in Canada," Health Policy, Elsevier, vol. 128(C), pages 28-33.

    More about this item

    Keywords

    cannabis; marijuana; dispensary; retail scanner data; Colorado; health; antacids; GERD; acid reflux;
    All these keywords.

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health
    • K4 - Law and Economics - - Legal Procedure, the Legal System, and Illegal Behavior

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ebl:ecbull:eb-19-00461. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: John P. Conley (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.